Can Splenic Infarction Cause Elevated Troponin?
Yes, splenic infarction can cause elevated troponin levels, though this is not a commonly recognized association in major cardiology guidelines. While splenic infarction is not explicitly listed among the standard non-cardiac causes of troponin elevation in the most authoritative guidelines, emerging evidence demonstrates this relationship exists, particularly in the context of systemic embolic disease.
Understanding Troponin Elevation Beyond Myocardial Infarction
The 2020 ESC Guidelines 1 and 2014 AHA/ACC Guidelines 2 provide comprehensive lists of conditions causing troponin elevation without acute coronary syndrome. The most important principle is that elevated troponin indicates cardiomyocyte injury but does not specify the mechanism. 1, 2
Recognized Non-Cardiac Causes Include:
- Critical illness (shock, sepsis, burns) 1
- Pulmonary embolism 1, 3
- Acute neurological events (stroke, subarachnoid hemorrhage) 1, 3
- Renal dysfunction 1, 2
- Respiratory failure 2
The Splenic Infarction-Troponin Connection
A 2019 prospective study 4 specifically demonstrated that patients with ischemic stroke and elevated troponin (≥0.1 ng/mL) were significantly more likely to have visceral infarcts, including splenic infarction. In this study:
- 39.1% of patients with positive troponin had visceral infarcts versus 15.0% with negative troponin (P=0.008)
- The adjusted odds ratio was 3.83 (95% CI 1.42-10.31, P=0.006)
- The authors concluded that troponin in this setting serves as a biomarker of embolic risk 4
Clinical Interpretation Framework
When encountering elevated troponin with splenic infarction:
1. Consider the Clinical Context
The diagnosis requires integration of clinical presentation, not troponin alone 1, 5. Look for:
- Abdominal pain (left upper quadrant)
- Evidence of systemic embolization
- Cardioembolic sources (atrial fibrillation, endocarditis, cardiac thrombus)
2. Assess the Troponin Pattern
Rising and/or falling troponin levels differentiate acute from chronic myocardial damage 1. In splenic infarction:
- The troponin elevation likely reflects concurrent cardiac injury from the same embolic process
- Static or minimally changing troponin suggests chronic elevation from other causes
- Absolute changes >3 ng/L (for hs-cTnT) or >2 ng/L (for hs-cTnI) suggest acute injury 6
3. Evaluate for Concurrent Cardiac Pathology
The troponin elevation may indicate:
- Type 2 MI from supply-demand mismatch if the patient is hemodynamically unstable
- Concurrent myocardial infarction from the same embolic source
- Underlying cardiac disease predisposing to both cardiac and splenic emboli
4. Rule Out Myocardial Infarction
Do not assume troponin elevation is solely from splenic infarction. 2, 7 Perform:
- Serial ECGs looking for ischemic changes
- Serial troponins (at 1-2 hours with high-sensitivity assays) 1
- Echocardiography if clinically indicated
- Consider coronary evaluation if clinical suspicion for ACS remains high
Critical Pitfalls to Avoid
- Never diagnose MI based on troponin alone - requires clinical evidence of myocardial ischemia 5
- Don't dismiss elevated troponin as "just from the spleen" - this may represent concurrent cardiac injury requiring intervention 2
- Recognize that modest troponin elevations (up to 3-fold the upper reference limit) have only 50-60% positive predictive value for AMI 1
- In critical illness or sepsis (which may accompany splenic infarction), troponin elevation is common and carries prognostic significance 1, 2
Practical Approach
When splenic infarction is identified with elevated troponin:
- Obtain serial troponins to assess for dynamic changes
- Perform ECG to evaluate for ischemic changes
- Search for embolic sources (echocardiography, rhythm monitoring)
- Assess for other end-organ damage from emboli
- Treat any identified cardiac pathology aggressively - elevated troponin indicates increased mortality risk regardless of cause 2, 7
- Consider anticoagulation if cardioembolic source identified
The troponin elevation in splenic infarction likely represents either concurrent myocardial injury from the same embolic process or reflects the systemic inflammatory and hemodynamic stress associated with visceral infarction and critical illness 1, 4.